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EXECUTIVE SUMMARY The Argus Commission examined changes that should be considered by
colleges and schools of pharmacy to meet the bold aim of better integrating pharmacists’ and physi-
cians’ practices articulated by President Sorensen. The Commission assessed the readiness of phar-
macy educators to contribute to the acceleration of practice transformation. The primary focus of the
report is on how the doctor of pharmacy curriculum and post-graduate training might be modified and
better aligned to ensure that graduates complete their education ready to engage in roles partnered with
primary care clinicians. The aim is to achieve comprehensive medication management and other
pharmacist patient care services as standards of care. The Argus Commission provides preliminary
recommendations for new or more intensified priorities by the 2020-21 AACP Strategic Planning
Committee as they update the AACP plan. This includes the recommendation that AACP should create
the Center for Academic Innovation and Practice Transformation, a hub to coordinate many current and
emerging activities relevant to accelerating change in pharmacy education and practice.
Keywords: education transformation, early career awareness, personalized education, experiential education,
post-graduate training, well-being and resilience
Committee Charges
TheArgusCommission is comprised of the fivemost
recent AACP presidents and is typically charged to study
a “horizon topic” believed to be germane to the future of
pharmacy education, research and/or practice. As part of
the examination of how academic pharmacy and AACP
could achieve the bold aim articulated by President Sor-
ensen in July 2019, the Argus Commission charge for
2019-20 was:
Conduct a critical analysis of the state of engagement
across academic pharmacy institutions with respect to
catalyzing practice transformation and preparing gradu-
ates to lead these efforts. Based on this critical analysis:
1. Describe what academic pharmacy must to do to
position pharmacists as a solution to the suboptimal
use of medications in our health care system.
2. Outline fundamental ways in which the training
pathway for pharmacists (from entrance to phar-
macy school through the completion of post-grad-
uate training and over the course of one’s career)
should evolve to best prepare graduates to lead
practice transformation and assume new roles in the
health care system.
3. With respect to the role of academic institutions in
transforming pharmacy practice, outline a set of rec-
ommendations that can guide initial discussions asso-
ciated with developing the next AACP strategic plan.
INTRODUCTION
President Todd Sorensen’s bold aim as stated in his
incoming presidential address sounds relatively simple:
that by 2025, 50% of primary care physicians in the U.S.
will have a formal relationship with a pharmacist.1 He
characterized this as fundamental to activating Strate-
gic Priority 3.4 in the current AACP strategic plan
which focuses on “practice advancement and transfor-
mation,” and specifically on interprofessional practice
and the role of AACP and its members in advancing
these partnerships.
The bold aim statement begs the question of “why?”
Don’t most physicians already have relationships with
pharmacists? Afterall, physicians remain the most































































productive initiators of prescribed medications for pa-
tients. State laws and pharmacy practice regulations in
virtually all states and territories now enable expanded
practice authority for pharmacists to initiate or modify
therapy, often in the form of collaborative practice
agreements with one or multiple prescribers.
Why aren’t thesewell-prepared clinicians able to use
their education and skills to the fullest to address medica-
tionproblems in theUShealth care system?Certainly, there
is evidence that some pharmacists are playing significant
roles in team-based care that improves patient outcomes
andminimizes harmbut toomanyare not yet able to expand
patient care services in many practice settings.
An implementation science project conducted by co-
investigators from the University of North Carolina
Eshelman School of Pharmacy and the University of
Minnesota College of Pharmacy with funding from the
American College of Clinical Pharmacists sought to ex-
amine the transformation of physician office practicewith
the systematic delivery of comprehensive medication
management by pharmacists working in these practices.
One publication describing this work grounds all types of
practice transformation efforts in a set of steps or pro-
cesses designed to yield sustainable transformation.2 The
2019-20 Research and Graduate Affairs Committee was
specifically charged to advance the appreciation and
practice of implementation science as a fundamental
component of practice transformation.
With this introduction as the backdrop for the
remaining work of the Argus Commission, the next sec-
tion of this report will identify areas of focused analysis
related to contemporary doctor of pharmacy education
with recommendations for how the academy might con-
sider modifications in both didactic and experiential
learning. The Commission believes that these changes
hold promise to increase the readiness for graduates to
enter practice more focused on how they can engage with
physicians and other prescribers to improve medication
safety and enhance patient outcomes. That said, theArgus
Commission believes that there must also be more pur-
poseful alignment between the initial PharmD education,
post-graduate residency and fellowship training and
lifelong learning in practice. This should enable new ed-
ucation and career pathways to evolve that prepare
pharmacists to lead practice transformation and assume
new roles.
Key Issues in Contemporary Pharmacy Education
The key areas of focus include recruitment and ad-
missions, early career guidance, the balance between
curricular content and application, experiential learning,
the articulation between PharmD education and post-
graduate learning, and student/faculty/practitioner well-
being and resilience.
Are we attracting enough of the right people to our
programs (change leaders, innovators)?
The lifeblood of every pharmacy college and school
is a high-quality applicant pool that impacts whether we
are attracting enough of the right people into our pro-
grams.Whetherwe are succeeding in attracting enough of
the right people will only be knownmany years from now
when our current students advance into the profession and
have had time to impact it. However, an evaluation of
several issues provides valuable insights for determining
whether our admissions programs are on target, includ-
ing achieving a diverse student population/workforce,
enriching the applicant pool for pharmacy programs,
varied levels of preparedness of potential and admitted
students, perceptions or misperceptions of pharmacy ca-
reers and the need for re-branding, and recognition of
faculty service. The report of the 2018-19 AACP Student
Affairs Committee provides a thorough treatment of rel-
evant issues regarding developing leaders in our student
bodies.3
Enhancing diversity in our applicant pool and our
student body is a priority across all the health professions.
This will ensure that the practitioners of the future mirror
the diversity of the populations served. This is also a key
point to ensuring that there is interest in pharmacy careers
among high school and undergraduate student pop-
ulations to maintain a robust and competitive applicant
pool, an aim that has become a significant challenge in
pharmacy education in the last several years. It is critical
that AACP and other organizations maintain proactive
outreach to prospective students, such as the Pharmacy Is
Right for Me4 campaign aligned with AACP Strategic
Priority #1. This program and others shine light on the
many career pathways available to pharmacy graduates.
Finally, pharmacy faculty play key roles in recruitment
and development of the student body. From advising, to
working with students in need of remediation, advising
student organizations, and modeling leadership and ser-
vice, these activities deserve recognition and encour-
agement as they can contribute to the development of
leaders and innovators for the profession.
In evaluating these issues, it is clear there are op-
portunities for improvement in our current programs.
Although only time will tell whether we are recruiting the
right people, what we can control today is addressing
these identified shortcomings. This will help ensure that
change leaders and innovators are being attracted to and
developed in our programs to positively impact the future
of our profession.































































Schools must aggressively develop a variety of
programs to offer applicants and students unique insights
into future career opportunities. When presented to ap-
plicants, they will establish clearer expectations for their
careers as the landscape for change across health care
continues to evolve.
How does early career guidance contribute to the
ability to prepare clinicians?
It is imperative that schools of pharmacy prepare
their students for the new careers that are being developed
in the next ten years.With respect to President Sorensen’s
bold aim, pharmacy educators will need to prepare a
significant number of graduates who are either practice
ready for ambulatory care positions upon graduation or,
ideally, with a PGY1 year of ambulatory care residency
training or other postgraduate options. This will ensure
that if we are able to create significant demand for these
practitioners there will be sufficient numbers of pharma-
cists to assume these positions. If students are to person-
alize their PharmD education to achieve this goal they
need access to excellent early career guidance that is in-
consistently available today, so they have the time and
flexibility to customize their didactic/elective/experien-
tial education curriculum.
There are several possible approaches and important
resources to support enhanced career guidance for pre-
pharmacy students as well as currently matriculated stu-
dents. This includes recruitment activities as emphasized
in the previous section, P1 year early career introduction
strategies and curricular flexibility with tracks for various
settings and specialty practice exposure.5 The required
interview is an excellent time to identify how enlightened
candidates are to the profession.
TheArgusCommission believes that all colleges and
schools of pharmacy should routinely monitor the
changes in health care and the emerging opportunities for
both faculty and students. AACP can assist members with
this priority, including facilitating sharing across pro-
grams. Colleges and schools need to consider what other
courses/programs could the schools offer across the cur-
riculum to prepare students for advanced practice op-
portunities. Popular programs include co-curricular
assignments, portfolios, student organization activities to
promote career advancements and opportunities to
shadow practitioners in diverse roles and settings.6 A
search for articles that used the term “early career guid-
ance” yielded 278 articles. Examples include specialty
tracks embedded in the curriculum (eg, residency track,
entrepreneurism), electives (eg, academia), dual degree
programs (eg, PharmD/MBA or MPH) and specialty
APPEs (eg, sports medicine or veterinary pharmacy).
There are other professional programs to assist
schools in providing career orientation and awareness.
Most colleges and schools utilize the APhA Career
Pathway Evaluation Program,7 typically early in the
PharmD curriculum. The two national public awareness
campaigns coordinated by AACP include profiles of di-
verse careers, including those associated with board cer-
tification through the Board of Pharmacy Specialties.
Several national associations offer training programs
which provide a certificate that students can note on their
resumes and/or CVs. The Argus Commission studied the
emerging program for students and practicing pharma-
cists created by APhA to enable lifelong learning and
career progression and believes that APhA Advance will
be another important tool to help learners develop career
plans early in their educational program.8
All these programs and resources support thework of
colleges and schools to identify existing and emerging
career opportunities and modify curricula and co-curric-
ular offerings to prepare graduates to be competitive upon
graduation and across their careers in the rapidly changing
work of pharmacy and health care.
What is the right balance between content knowledge
and application?
As the practice of pharmacy has become more spe-
cialized, especially in the institutional setting, and more
graduates are pursuing post-graduate residencies, phar-
macy education needs to explorewhether a one size fits all
approach to the curriculum is the best approach for all
students. Do students who are preparing for a career pri-
marily providing comprehensive medication manage-
ment (CMM) services for patients in ambulatory care
settings and community pharmacies need the same degree
of content in all areas as does a student who plans to
specialize and pursue two years of post-graduate training
in areas such as oncology, critical care, or psychiatry?
Should the curriculum provide two levels of content
coveragewithmore general topics covered in depth for all
students along with less intense coverage of content from
specialty areas? Students headed for careers in specialty
areas could then enroll in elective courses that cover
content of these topics in greater detail. Students headed
for careers in ambulatory care practice would then have
the opportunity to take courses where the application of
content and the implementation of CMM services could
be addressed and assessed in greater detail.9
The question about the value and purpose of the
APPE component of the curriculum must be considered.
Are there curricular content elements and skills that are
best introduced and assessed in the experiential portion of
the curriculum and should greater emphasis be placed on































































teaching and assessing the application of content in the
didactic portion of the curriculum? Schools of medicine
are currently grappling with the focus on competency-
based education and if the transition frommedical school
to residency could be accelerated. Greater value might be
achieved during the fourth year of medical school. The
same argument could be made for pharmacy education.
Accelerated medical programs have been developed in
pediatrics and family medicine. Pharmacy students
headed for a career providingCMMservices to patients in
ambulatory care settings might be better served during
their final year concentrating on quality ambulatory care
APPEs in multiple sites learning from a variety of
established preceptors. These learning experiences could
focus not only on the application of knowledge but also on
how to implement these types of value driven pharmacy
services in locations where they do not yet exist. For this
to happen, ACPE would have to modify the requirements
for APPEs and, in general, increase flexibility in the ac-
creditation process.10-12
Completion of a competency-based didactic curric-
ulum focusing on the application and implementation of
CMM services provides opportunities for enhanced in-
struction. Experienced APPE preceptors would assess
students’ ability to apply their knowledge and acquire
implementation skills and abilities. Students completing
enhanced ambulatory care courses with extended ambu-
latory careAPPEexperiencesmight be able to enter PGY-
1 residencies at an advanced level and perhaps be ready to
enter practice with the knowledge and skills necessary to
implement and expand CMM services to more patients
and providers. Likewise, students with a desire and ability
to customize their didactic and APPE experiences will be
better prepared for their post-graduate employment, res-
idency, or fellowship education and training.12,13
The option of an accelerated transition to practice or
residency predicated on a competency-based curriculum,
with the centerpiece being amore customized fourth year,
could provide numerous benefits and a rethinking of how
we have taught and delivered content for so long. Any
dramatic changes must be carried out using sound edu-
cational strategies utilizing the appropriate levels of as-
sessment tied to scholarship. This future practitioner,
prepared to deliver, implement, and expand CMM de-
livery in primary care, will enhance patient outcomes.We
must reexamine how content and its practice application
are taught and assessed in our schools and colleges.14
How might changes in experiential education address
the “bold aim”?
As experiential learning evolved, the early 2000s
were especially challenging because the entry-level
PharmD meant many more APPEs were needed for a
wider variety of required and elective practice settings.
The implementation of Introductory Pharmacy Practice
Experiences (IPPE) put additional pressure on experien-
tial capacity. As the number of pharmacy colleges and
schools and satellite campuses increased, experiential
programs were stretched to their limits to satisfy the
ACPEbasic requirements for all students and competition
for sites increased. A preceptor resignation or student
rotation failure might result in double-booking a rotation
experience to satisfy requirements. Also, the gradual in-
crease in pharmacy residencies created capacity chal-
lenges when some experienced preceptors preferentially
aligned with residency programs and limited the total
number of learners.
With the variation among colleges and schools in the
years of PharmDprogram length (eg, 3 calendar years vs 4
academic years), local facilities/resources, and practice
partners, the concept of practice transformation seems an
enormous challenge. Is it time for experiential education
formats, assumptions, and rules established for the entry-
level PharmD to be re-examined, re-considered, or
reformed?
Experiential Education Survey and Responses
The 2018-2019 Professional Affairs Committee re-
port provided examples of support for preceptors to ad-
vance practice transformation.15 The 2019-20 Argus
Commission surveyed experiential directors/leaders for
guidance and direction for potential administrative effi-
ciencies such as clinical tracks to advance the bold aim for
medication management services in primary care.16 Ex-
periential Education Section leaders provided input into
the survey questions.
The 55 respondents served as a virtual focus group
for the broad findings.
d Total APPEs (in weeks) ranged from 36 to 66.
d Approximately 40% reported that they had imple-
mented concentrations (or tracks or blocks) for
APPEs.
d Of the 22 respondents with tracks, 40% offered
ambulatory care tracks, 50% offered acute care
tracks, 23% providedmanaged care tracks, and 73%
offered others. (Multiple selections were allowed on
the survey.)
d Regarding medication management services at am-
bulatory care sites, 36% reported that 100% of the
sites met the definition, with the remainder between
99% and 25%.
The pharmacy experiential education community,
including experiential program directors, preceptors,
school administrators, practice site personnel, employers,
patients, and public health community groups, have































































shared interests in simplification and streamlining of ex-
periential education to maximize student experiences and
minimize administrative burdens. One director stated
simply, “overloaded and not much time to be truly stra-
tegic.” Reduced student enrollments at some institutions
have resulted in fewer faculty to support and precept ex-
periential rotations. Practice sites are increasingly stipu-
lating limits to their experiential involvement in terms of
numbers of students, selected partner schools, types of
rotations, and expectations for resources.
The pharmacy experiential education stakeholders
should be activated for a stakeholders’ conference for
recommendations to expedite the adoption of the primary
care goal. These questions from experiential program
directors and Argus Commission members should be
considered.
d Rather than requiring certain types of rotations, how
could competencies be tracked and accomplished
across all APPE rotations? Would students become
more proficient and competent?
d What could be learned from three-year PharmD
programs which complete didactic courses in two
years?
d We have long produced generalist pharmacists with
one degree, but some schools offer students a de-
clared pathway (much like minors in undergraduate
programs). Could pathways promote focused com-
petence for in-demand areas, especially for students
not planning on residency training?
d How can schools/colleges assure all rotations are
rigorous? Is performance (achievement of out-
comes) being properly assessed?
d Should ALL students be prepared for health care
teams in primary care or should there be ‘letters of
intent’ at the academic midpoint for those
interested?
With the experiential component of the pharmacy
curriculum in mind, the Argus Commission supports the
use of implementation science with stakeholder buy-in,
similar to that described by Livet and colleagues,2 to
coordinate and accelerate comprehensive medication
management proficiency for pharmacy students.
Residencies and alternative models of preparation to
meet the bold aim
Achievement of practice transformation goals may
require rethinking and redesigning both the PharmD
curriculum and residency experience. The curricula of
doctor of pharmacy programs as well as the content of
residency programs have advanced incrementally over
the past 20 years without sufficient coordination between
the two. Residency planning and standard setting occurs
in a manner disengaged from PharmD degree curriculum
planning and standard setting. Engle and colleagues
recently demonstrated that competencies of clinical
pharmacists, residency programs and PharmD degree
programs require consistent terminology and better
alignment.17
This has led to questions about the efficiency of both
programs, including:
d Can PharmDdidactic and experiential curriculum as
currently administered adequately prepare gradu-
ates to assume progressive, entry-level, patient-ori-
ented pharmacist practice roles?
d Can the experiential component of PharmD degree
programs be enhanced to provide training on the
level now provided by PGY1 residency programs?
d What can be done within PharmD curricula that
might reduce the necessary duration of a residency?
d In light of the need for primary care practitioners and
the extensive debt load that pharmacy graduates
acquire, can the time and cost of education and
training be reduced by better coordination between
degree and residency programs?
To achieve comprehensive practice transformation
thought and action should be directed to better coordi-
nating PharmD degree and residency training, including:
d Better coordination between PharmD programs and
residencies to achieve the greatest learning value
from each. Parties involved in PharmD education
and residency training should consider holding a
“Summit Conference” to address inter-program
coordination.
d Expansion of residency positions to accommodate
all graduates who desire to have that experience and
provide adequate numbers of practitioners ready to
assume progressive practice roles.
d Enhancement of both PharmD education and resi-
dency training in domains that are likely to be more
highly valued in the future, including wellness and
population heath, coordinated team care, data sci-
ence, personalized medicine, patient safety, and
supply chain management.
d Identification of training pathways other than resi-
dency which could lead to attractive, progressive
careers for pharmacy graduates.
Addressing the Well-being and Resilience of Students,
Faculty and Practitioners
Even prior to the COVID-19 pandemic, the Argus
Commission acknowledged that this is a time of signifi-
cant change in both education and practice. Strategic
Priority 3 in the currentAACP strategic plan even calls for
the acceleration of change in both practice and education.































































It is important to ask what is currently being done to assist
our learners and their teachers, including preceptors, in
addressing the stress that accompanies pervasive change.
Further, what more needs to be done to assure the well-
being of all those in the pharmacy profession. Each of
these groups merit more intense scrutiny as we progress
from the acute response to the pandemic and consider
needs in the intermediate and longer terms.
In July 2019, APhA, in collaboration with AACP,
ACPE, NABP and National Alliance of State Pharmacy
Associations, convened the Enhancing Well-Being and
Resilience Among the Pharmacist Workforce: A Na-
tional Consensus Conference.18 Diverse stakeholders
within the profession—representing pharmacists and
employers from across practice settings, schools and
colleges of pharmacy, and professional organizations—
came together and engaged in a thoughtful and intentional
process to discuss issues and concerns associated with
well-being, moral distress, work overload, and burnout.
The goal of the conference was the development and
approval of meaningful and actionable recommendations
that can be effectively implemented broadly to address
this important issue.
Both AACP and APhA have subsequently analyzed
the 50 conference recommendations to identify those that
are most germane to and demanding action by the Asso-
ciation and our members. Through programming, re-
search and communications, AACP and our members are
dedicated to helping the profession navigate this period of
profound change with appropriate strategies that work to
decrease stress and burnout and increase well-being and
resilience.
DISCUSSION – IMPLICATIONS FOR THE
2021 AACP STRATEGIC PLAN
Each of the six standing committees, including the
Argus Commission, was charged with one aspect of
operationalizing President Sorensen’s bold aim into plans
for action. In the case of Argus, the Commission’s work
included the request to provide input into the forthcoming
AACP strategic plan for 2021 and the years that follow.
The Commission sought evidence of how colleges
and schools of pharmacy might be engaged in practice
transformation, broadly defined. There is substantial ev-
idence of contributions the academy has made to pro-
gressive and innovative pharmacy practice models over
several decades. Pharmacy faculty members have stim-
ulated creation of advanced clinical roles in institutional
settings, with growing attention to ambulatory care ser-
vices often associated with chronic disease management.
The current engagement of almost 100 AACP member
institutions and their faculty in the Academic CPESN
Transformation Collaborative is further indication of
academic pharmacy’s commitment to and engagement in
practice and education transformation.
Curriculum committees across the academy struggle
to make curricular change that keeps pace with the rapid
expansion of content as research provides new therapeutic
agents and new areas of foundational science (eg, phar-
macogenomics). Hence, the Argus Commission encour-
ages a dialogue among our members related to models
that allow a learner to identify a pathway early in the
educational process and the flexibility to customize some
portion of the didactic and experiential curriculum. The
goal is to prepare individuals who are truly “practice
ready” as emphasized in the current accreditation stan-
dards. The need for practice readiness upon graduation
has also been one of many lessons associated with the
COVID-19 pandemic. The current Argus Commission
encourages AACP to carefully analyze such lessons in an
effort to lead the academy in future crises that are sure to
arise.
The Argus Commission also recognized that there is
not adequate alignment between the evolution of curric-
ula and the current post-graduate training models. Our
recommendations include a call for a national summit to
engage all the stakeholders in a timely and important
conversation about how to work toward an enhanced
education continuum for different career pathways.
The Argus Commission began the process of pro-
viding input into AACP’s next strategic plan by exam-
ining the results of an institutional membership survey
administered by iBossWell, the consulting firm engaged
for the planning process. Fielded in late 2019, the survey
was completed by more than 100 deans. Results from a
second survey that was sent in early 2020 to all current
individual members except for the deans were not avail-
able while the Commission completed this part of their
charges due to the disruption of the pandemic. The 2020-
21 AACP Strategic Planning Committee will have data
fromboth surveys as they begin theirwork later in 2020.A
separate report with planning recommendations will be
provided by the Argus Commission to the planning
committee.
In closing, an article entitled “AHistorical Discourse
Analysis of Pharmacist Identity in Pharmacy Education”
reviews themes in the profession of pharmacy through the
pharmacy education literature.19 Predominant discourses
are “apothecary,” “dispenser,” “merchandiser,” “expert
advisor,” and “health care provider.” These roles do not
expire when the next role appears. The authors posit
that attempts to transform the pharmacy profession may
“illustrate the profession’s robust adaptability and resil-
ience in an every-changing health care environment.”































































However, “it is unclear if our educational institutions
have been unsuccessful in socializing students to the
health care provider identity or if our practice settings
undo this identity, or a combination of both.” This is an
important dilemma for addressing the bold aim in primary
care.
Policy Statements, Recommendations and
Suggestions
The Argus Commission reviewed the 1980-2019
compendium of current AACP policy to identify those
most relevant to their current charges. Several dozen
policy statements were identified, including two of
AACP’s older statements that bear repetition.
AACP should encourage member institutions, in
concert with practitioners, to expand clinical phar-
macy in the community so that clerkships in com-
munity settings will be more meaningful to students,
and even inspirational, so that such practices will be
emulated when they enter the profession. (Source:
Policy Development Committee, 1982)
AACP supports the teaching and clinical application
of core competencies in primary care health services
delivery which are community-based and fully in-
terprofessional. (Source: Argus Commission, 2010,
as revision to policy proposed by the Professional
Affairs Committee, 1994)
Proposed Policy Statement (submitted to the Bylaws and
Policy Development Committee)
The 2019-20 Argus Commission proposes one new
policy statement:
AACP encourages the design and delivery of curricular
models that facilitate students’ identification of early
career preferences and the personalization of electives
in the didactic and experiential components of the
PharmD program as well as post-graduate training
and practice. (Source: Argus Commission 2019-20)
Recommendations
Recommendation 1: Establishment of the Center for
Academic Innovation and Practice Transformation
AACP should establish and resource the Center for
Academic Innovation and Practice Transformation
as a new organizational unit that will drive the As-
sociation’swork to accelerate education and practice
transformation.
Recommendation 2: Convening a Stakeholder Summit to
Align PharmD and Residency Training
AACP should lead the planning and execution of a
summit with all relevant stakeholders to examine
inter-programcoordination to enhance the efficiency
of both PharmD and residency training programs.
Recommendation 3: Critical Examination of the COVID-
19 Pandemic Impact on Academic Pharmacy
The 2020-21 Argus Commission (or some other body)
should be chargedwith a critical analysis of the impact
of the COVID-19 pandemic on academic pharmacy,
including short, intermediate and long-term impacts,
and identify proactive strategies to mitigate negative
impacts and increase readiness for a future crisis.
Recommendation 4:
The 2020-21 Bylaws and Policy Development Com-
mittee should be charged with responsibility for crit-
ically examining the 1980-2020 AACPCompendium
of Policies to identify those policies that should be
archived or repealed. Further, the BPDC should
identify an updated format to make the compendium
more searchable and user-friendly.
Suggestions
Suggestion 1: Increasing Member Engagement
AACP encourages pharmacy colleges and schools to
engage with practice leaders in ambulatory and com-
munity pharmacypractice plus primary care providers in
themedicalcommunities to facilitate the incorporationof
implementation strategies for delivery of comprehensive
medication management and other patient care services
into curricula, including experiential education.
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